NCT03655756 2022-08-08pDNA Intralesional Cancer Vaccine for Cutaneous MelanomaTuHURA Biosciences, Inc.Phase EARLY_PHASE1 Completed7 enrolled 9 charts
NCT00535769 2012-07-20Evaluation of Adherence to Topical Agents: Applying Communication Technology to Improve Sunscreen UseMassachusetts General HospitalPhase EARLY_PHASE1 Completed70 enrolled 7 charts